Magmole AI-accelerated
Drug Discovery for
Precision Medicine
End-to-end AI-based Drug Discovery Services
Our AIDD platform accelerate the design of highly selective and potent drugs for Receptor, Protein and RNA targets.
Structural Modeling/Docking
Enhance Structural-Based Drug Design through precision in structure modeling/docking to identify small molecule-target interaction at molecular level.
AI-Based Screening
Proprietary AI-based screening that accelerate hit identification process in < 4 weeks. Our AI-based technology screen up to 3 million compounds on Receptor, protein and RNA targets.
Hits Characterization
Iteration of experimental data from biophysical and functional cell-based assays.
Small Molecule AI Knowledge Engine
Our engine is a robust scientific data processor trained to establish small molecule targeting Receptor, Protein and RNA to accelerate hit identification process and enable structural based drug design.
Collaborations & Partnerships
Revolutionize Drug Discovery with Integrated AI Solutions